Literature DB >> 15768855

Transient and widespread astroglial activation in the brain after a striatal 6-OHDA-induced partial lesion of the nigrostriatal system.

V C Gomide1, G A Silveira, G Chadi.   

Abstract

The authors have previously described astroglial activation in the ipsilateral nigrostriatal system and ventral tegmental area following small doses of 6-hydroxydopamine (6-OHDA) injected unilaterally in the striatum. This article further evaluated astroglial reactivity in several brain regions after striatal 6-OHDA-induced punctate lesion in the nigrostriatal pathway. Adult male Wistar rats received a unilateral stereotaxical injection of the 6-OHDA (8 microg/4 microl) in the neostriatum and sacrificed 1 or 3 weeks later. Control animals received only solvent. Immunohistochemistry was employed for visualization of the tyrosine hydroxylase (TH), marker for dopamine cells, and glial fibrillary acidic protein (GFAP), marker for astrocytes. TH immunoreactive terminals disappeared in the striatum close to the injection site and a disappearance of a small number of a defined population of dopamine cell bodies was observed in the ipsilateral pars compacta of the substantia nigra (SNc). No dopamine lesion was detected in the contralateral nigrostriatal pathway. Astroglial reaction was seen close to the lesion in the neostriatum and in the ipsilateral SNc of the 1 week 6-OHDA lesioned rats. Specific stereological tools employing point intercepts and rotator, revealed an increased presence of reactive astrocytes in many forebrain regions like frontal, parietal and piriform cortex, septum, neostriatum and SNc, bilaterally, and also corpus callosum after 1 week of 6-OHDA injection. The astroglial activation was characterized by increases in the size of the cell body and/or processes. Astrocytic reaction was found only in the ipsilateral nigrostriatal pathway by 3 weeks of 6-OHDA, a slight activation also remaining in the ipsilateral septum and piriform cortex. Astrocytic reaction was seen in the solvent-injected rats only in the neostriatum close to the needle track. The transient widespread astroglial reaction observed in many brain regions following a striatal injection of 6-OHDA may represent a global paracrine trophic response in the brain.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15768855     DOI: 10.1080/00207450490512696

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  8 in total

1.  Exercise improves motor deficits and alters striatal GFAP expression in a 6-OHDA-induced rat model of Parkinson's disease.

Authors:  Márcio Ferreira Dutra; Mariane Jaeger; Jocemar Ilha; Pedro Ivo Kalil-Gaspar; Simone Marcuzzo; Matilde Achaval
Journal:  Neurol Sci       Date:  2012-01-10       Impact factor: 3.307

2.  Differential cellular FGF-2 upregulation in the rat facial nucleus following axotomy, functional electrical stimulation and corticosterone: a possible therapeutic target to Bell's palsy.

Authors:  Karen F Coracini; Caio J Fernandes; Almir F Barbarini; César M Silva; Rodrigo T Scabello; Gabriela P Oliveira; Gerson Chadi
Journal:  J Brachial Plex Peripher Nerve Inj       Date:  2010-11-09

3.  Antioxidant and Anti-Apoptotic Activity of Octadecaneuropeptide Against 6-OHDA Toxicity in Cultured Rat Astrocytes.

Authors:  Hadhemi Kaddour; Yosra Hamdi; Fatma Amri; Seyma Bahdoudi; Ibtissem Bouannee; Jérôme Leprince; Sami Zekri; Hubert Vaudry; Marie-Christine Tonon; David Vaudry; Mohamed Amri; Sana Mezghani; Olfa Masmoudi-Kouki
Journal:  J Mol Neurosci       Date:  2018-10-20       Impact factor: 3.444

4.  Enriched environment protects the nigrostriatal dopaminergic system and induces astroglial reaction in the 6-OHDA rat model of Parkinson's disease.

Authors:  Agustín Anastasía; Luciana Torre; Gabriel A de Erausquin; Daniel H Mascó
Journal:  J Neurochem       Date:  2009-02-20       Impact factor: 5.372

5.  Striatal Injury with 6-OHDA Transiently Increases Cerebrospinal GFAP and S100B.

Authors:  Cristiane Batassini; Núbia Broetto; Lucas Silva Tortorelli; Milene Borsoi; Caroline Zanotto; Fabiana Galland; Tadeu Mello Souza; Marina Concli Leite; Carlos-Alberto Gonçalves
Journal:  Neural Plast       Date:  2015-05-18       Impact factor: 3.599

6.  Evaluation of exercise-induced modulation of glial activation and dopaminergic damage in a rat model of Parkinson's disease using [11C]PBR28 and [18F]FDOPA PET.

Authors:  Caroline C Real; Janine Doorduin; Paula Kopschina Feltes; David Vállez García; Daniele de Paula Faria; Luiz R Britto; Erik Fj de Vries
Journal:  J Cereb Blood Flow Metab       Date:  2017-12-22       Impact factor: 6.200

7.  High-frequency stimulation of the subthalamic nucleus modifies the expression of vesicular glutamate transporters in basal ganglia in a rat model of Parkinson's disease.

Authors:  Mathieu Favier; Carole Carcenac; Guillaume Drui; Sabrina Boulet; Salah El Mestikawy; Marc Savasta
Journal:  BMC Neurosci       Date:  2013-12-05       Impact factor: 3.288

8.  Transplantation of Human Neural Stem Cells in a Parkinsonian Model Exerts Neuroprotection via Regulation of the Host Microenvironment.

Authors:  Fu-Xing Zuo; Xin-Jie Bao; Xi-Cai Sun; Jun Wu; Qing-Ran Bai; Guo Chen; Xue-Yuan Li; Qiang-Yi Zhou; Yuan-Fan Yang; Qin Shen; Ren-Zhi Wang
Journal:  Int J Mol Sci       Date:  2015-11-05       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.